News Column

ACADIA HEALTHCARE COMPANY, INC. FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits

June 17, 2014

Item 1.01. Entry into a Material Definitive Agreement.

Fifth Amendment to Amended and Restated Credit Agreement

On June 16, 2014, Acadia Healthcare Company, Inc. (the "Company") entered into a Fifth Amendment to its Amended and Restated Credit Agreement, dated as of December 31, 2012. The Fifth Amendment specifically permits the Company's acquisition of Partnerships in Care, gives the Company the ability to incur a tranche of term loan B debt in the future through its incremental credit facility, and modifies certain of the restrictive covenants on miscellaneous investments and incurrence of miscellaneous liens. The restrictive covenants on investments in joint ventures and foreign subsidiaries were also amended such that the Company may now invest, in any given fiscal year, up to five percent (5%) of its total assets in both joint ventures and foreign subsidiaries, respectively; provided that the aggregate amount of investments in both joint ventures and foreign subsidiaries, respectively, may not exceed ten percent (10%) of its total assets over the life of the Amended and Restated Senior Credit Facility; provided further that the aggregate amount of investments made in both joint ventures and foreign subsidiaries collectively pursuant to the foregoing may not exceed fifteen percent (15%) of its total assets. Finally, the Fifth Amendment provided increased flexibility to the Company in terms of its financial covenants, as described in the charts below.

As amended by the Fifth Amendment, the Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with customary affirmative, negative and financial covenants. A breach of any of the restrictions or covenants in the Company's debt agreements could cause a cross-default under other debt agreements. The Company may be required to pay all of its indebtedness immediately if it defaults on any of the numerous financial or other restrictive covenants contained in any of its material debt agreements. Set forth below is a brief description of such covenants, all of which are subject to customary exceptions, materiality thresholds and qualifications:

(a) the affirmative covenants include the following: (i) delivery of financial statements and other customary financial information; (ii) notices of events of default and other material events; (iii) maintenance of existence, ability to conduct business, properties, insurance and books and records; (iv) payment of taxes; (v) lender inspection rights; (vi) compliance with laws; (vii) use of proceeds; (viii) further assurances; and (ix) additional collateral and guarantor requirements. (b) the negative covenants include limitations on the following: (i) liens; (ii) debt (including guaranties); (iii) investments; (iv) fundamental changes (including mergers, consolidations and liquidations); (v) dispositions; (vi) sale leasebacks; (vii) affiliate transactions; (viii) burdensome agreements; (ix) restricted payments; (x) use of proceeds; (xi) ownership of subsidiaries; (xii) changes to line of business; (xiii) changes to organizational documents, legal name, state of formation, form of entity and fiscal year; (xiv) prepayment or redemption of certain senior unsecured debt; and (xv) amendments to certain material agreements. The Company is generally not permitted to issue dividends or distributions other than with respect to the following: (w) certain tax distributions; (x) the repurchase of equity held by employees, officers or directors upon the occurrence of death, disability or termination subject to cap of $500,000 in any fiscal year and compliance with certain other conditions; (y) in the form of capital stock; and (z) scheduled payments of deferred purchase price, working capital adjustments and similar payments pursuant to the merger agreement or any permitted acquisition.


(c) the financial covenants include maintenance of the following: the fixed charge coverage ratio may not be less than 1.25:1.00 as of the end of any fiscal quarter; as of the dates set forth below, the consolidated leverage ratio may not be greater than (i) if the Bridge Senior Unsecured Indebtedness (as defined in the Amended and Restated Credit Agreement) is not incurred, the ratio set forth in Column A and (ii) if the Bridge Senior Unsecured Indebtedness is incurred the ratio set forth in Column B: Maximum Consolidated Fiscal Quarter Ending Leverage Ratio(1) Column A Column B June 30, 2014 5.75:1.0 7.25:1.0 September 30, 2014 5.75:1.0 7.25:1.0 December 31, 2014 5.50:1.0 6.50:1.0 March 31, 2015 5.50:1.0 6.50:1.0 June 30, 2015 5.50:1.0 6.50:1.0 September 30, 2015 5.50:1.0 6.50:1.0 December 31, 2015 5.25:1.0 5.75:1.0 March 31, 2016 5.25:1.0 5.75:1.0 June 30, 2016 5.25:1.0 5.75:1.0 September 30, 2016 5.25:1.0 5.75:1.0 December 31, 2016 5.00:1.0 5.00:1.0 March 31, 2017 5.00:1.0 5.00:1.0 June 30, 2017 5.00:1.0 5.00:1.0 September 30, 2017 5.00:1.0 5.00:1.0

December 31, 2017 and each fiscal quarter ending thereafter 4.50:1.0 4.50:1.0

(1) The Company does not expect to incur Bridge Senior Unsecured Indebtedness.

The consolidated senior secured leverage ratio may not be greater than the amount set forth below as of the date opposite such ratio: Maximum Consolidated Senior Secured Fiscal Quarter Ending Leverage Ratio June 30, 2014 3.75:1.0 September 30, 2014 3.75:1.0 December 31, 2014 3.75:1.0 March 31, 2015 and each fiscal quarter ending thereafter 3.50:1.0

. . .

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an

Off-Balance Sheet Arrangement of a Registrant.

To the extent required, the information set forth in Item 1.01 above is incorporated by reference into this Item 2.03.


Item 8.01. Other Events. Senior Note Offering

On June 17, 2014, the Company issued a press release announcing it is proposing to issue $300 million aggregate principal amount of senior unsecured notes due 2022 to be offered and sold only to qualified institutional buyers in an unregistered offering pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Act"), and to certain non-U.S. persons in transactions outside the United States in reliance on Regulation S under the Act. A copy of the press release is attached as Exhibit 99 to this Form 8-K.

Equity Offering Closing and Exercise of Underwriters' Over-Allotment Option

As previously reported, Acadia entered into an underwriting agreement, dated June 11, 2014 (the "Underwriting Agreement"), with Merrill Lynch, Pierce, Fenner & Smith Incorporated and Jefferies LLC, as representatives of the several underwriters named therein (collectively, the "Underwriters"), and the selling stockholder named therein (the "Selling Stockholder") in connection with the sale by Acadia (the "Offering") of an aggregate of 7,727,273 shares (the "Firm Shares") of Acadia's common stock, par value $0.01 per share ("Common Stock"), at a public offering price of $44.00 per share (the "Public Offering Price"). Pursuant to the Underwriting Agreement, Acadia and the Selling Stockholder granted the Underwriters a 30-day option to purchase an aggregate of up to an additional 1,159,090 shares of Common Stock (the "Option Shares"), which includes up to 1,154,521 additional shares from Acadia and up to 4,569 additional shares from the Selling Stockholder, at the Public Offering Price.

On June 13, 2014, the Underwriters exercised their option to purchase all of the Option Shares.

The sale of the Firm Shares and the Option Shares is expected to be completed on June 17, 2014. The total net proceeds from the offering to Acadia, after underwriting discounts and commissions and estimated offering expenses, will be approximately $374.0 million. Acadia intends to use the net proceeds principally to fund its acquisition strategy, particularly the planned acquisition of Partnerships in Care, and otherwise for general corporate purposes. Acadia will not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholder.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. Exhibit Number Description 10 Fifth Amendment, dated June 16, 2014, to the Amended and Restated Credit Agreement, dated December 31, 2012, by and among Bank of America, NA (Administrative Agent, Swing Line Lender and L/C Issuer) and the Company (f/k/a Acadia Healthcare Company, LLC), the guarantors listed on the signature pages thereto, and the lenders listed on the signature pages thereto. 99 Press release, dated June 17, 2014.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters